Melanoma UK appoints Rachel Wallace as new Chief Executive Officer.13 October 2026Melanoma UK appoints Rachel Wallace as new Chief Executive Officer. Melanoma UK has appointed…
Funding Research at Kings College London8 October 2026Ground breaking research at King’s On Wednesday 7th October Colin (our C.O.O.) visited King’s…
Luke’s going down under to bite against cancer1 October 2026Facing fears and fighting cancer with a Great White Shark challenge. After facing two…
Ryan completes Robin Hood Half Marathon29 September 2026A huge thank you to Ryan Mcevoy who ran the Robin Hood Half Marathon…
New National Cancer Board launched22 September 2026The Department of Health and Social Care (DHSC) has announced the launch of a…
Melanoma UK announces Rachel Wallace as new Chief Executive14 September 2026Melanoma UK announces Rachel Wallace as new Chief Executive Melanoma UK is delighted to…
Merck & Moderna announce encouraging trial results20 August 2026A personalised cancer treatment developed by Moderna and Merck has shown positive trial results…
Our 2026 Research Grants Announced13 August 2026Melanoma UK continues to support leading research projects. Our charity is delighted to announce…
CRUK’s National Medical Trial looking to increase recruitment30 July 2026‘DETERMINE’ is Cancer Research UK’s national precision medicine trial for patients with rare and…